More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

1H24 investor presentation

Feb 27, 2024 at 9:28 PM EST · Issued by Australian Clinical Labs Ltd

Filed with ASX · Feb 27, 2024 at 9:28 PM EST

On 6ix: 6ix.com/news/1h24-investor-presentation-4

Australian Clinical Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Australian Clinical Labs Ltd on 6ix

In the deck

  • Australian Clinical Labs — Investor Presentation (February 2024)25 slidesFeb 28, 2024

Earlier from Australian Clinical Labs

  • Notice of withdrawal of offer - Healius LimitedDec 21, 2023
  • HLS: ACCC Rejection&ACL Notice of Intention to Withdraw OfferDec 15, 2023
  • Intention to withdraw takeover offer for HealiusDec 14, 2023
  • AXX: Accc opposes Australian Clinical Labs' proposed acquisDec 14, 2023
  • Takeover offer - Healius entitlement offerNov 20, 2023

Later from Australian Clinical Labs

  • FY24 Trading UpdateMay 21, 2024
  • Appendix 4E and FY24 financial statementsAug 28, 2024
  • FY24 financial results investor presentationAug 28, 2024
  • Notification of buy-back - ACLAug 28, 2024
  • Sale of Crescent Capital shareholdingSep 11, 2024
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer